ATTENUFERON Trademark

Trademark Overview

On Friday, October 25, 2013, a trademark application was filed for ATTENUFERON with the United States Patent and Trademark Office. The USPTO has given the ATTENUFERON trademark a serial number of 86101853. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 10, 2017. This trademark is owned by TEVA Pharmaceutical Industries Limited. The ATTENUFERON trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancer and autoimmune diseases
attenuferon

General Information

Serial Number86101853
Word MarkATTENUFERON
Filing DateFriday, October 25, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 10, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 7, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cancer and autoimmune diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, November 1, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTEVA Pharmaceutical Industries Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressJerusalem 91010
IL
Party NameTEVA Pharmaceutical Industries Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressJerusalem 91010
IL

Trademark Events

Event DateEvent Description
Monday, April 10, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, April 10, 2017ABANDONMENT - NO USE STATEMENT FILED
Thursday, September 15, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 14, 2016EXTENSION 5 GRANTED
Thursday, August 25, 2016EXTENSION 5 FILED
Wednesday, September 14, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, August 25, 2016TEAS EXTENSION RECEIVED
Tuesday, March 1, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 26, 2016EXTENSION 4 GRANTED
Friday, February 26, 2016EXTENSION 4 FILED
Friday, February 26, 2016TEAS EXTENSION RECEIVED
Tuesday, September 1, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 28, 2015EXTENSION 3 GRANTED
Friday, August 28, 2015EXTENSION 3 FILED
Friday, August 28, 2015TEAS EXTENSION RECEIVED
Monday, June 1, 2015APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, June 1, 2015TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, February 6, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 4, 2015EXTENSION 2 GRANTED
Wednesday, February 4, 2015EXTENSION 2 FILED
Wednesday, February 4, 2015TEAS EXTENSION RECEIVED
Friday, September 5, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 3, 2014EXTENSION 1 GRANTED
Wednesday, September 3, 2014EXTENSION 1 FILED
Wednesday, September 3, 2014TEAS EXTENSION RECEIVED
Tuesday, March 4, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 7, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 7, 2014PUBLISHED FOR OPPOSITION
Wednesday, December 18, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 3, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 3, 2013ASSIGNED TO EXAMINER
Friday, November 1, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, October 29, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

attenuferon autoimmune diseases cancer treatment preparations pharmaceutical